CN101244206A - Pharmaceutical combination for treating cerebral thrombus and preparation thereof - Google Patents
Pharmaceutical combination for treating cerebral thrombus and preparation thereof Download PDFInfo
- Publication number
- CN101244206A CN101244206A CNA2007100640008A CN200710064000A CN101244206A CN 101244206 A CN101244206 A CN 101244206A CN A2007100640008 A CNA2007100640008 A CN A2007100640008A CN 200710064000 A CN200710064000 A CN 200710064000A CN 101244206 A CN101244206 A CN 101244206A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight
- portions
- radix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine composition for treating cerebral thrombosis as well as the preparation method, comprising the following active pharmaceutical ingredients: notopterygium, rhizoma gastrodiae, long-noded pit viper, chilopod, chrysanthemum, scorpion, pangolin, leech, tabanus, earthworm, calamus, danshen root, storax, benzoin, weeping forsythia nut, herba taxilli, fried eucommia bark, apocynum venetum, safflower, peach nut, root of herbaceous peony, angelica sinensis, woodlouse, pubescent angelica, zaocys dhumnades, fructus liquidambaris, cortex periplocae, herba lycopodii and Chinese starjasmine stem. The medicine composition is made into a preparation accepted clinically according to the conventional craft. The medicine composition has good curative effect for treating cerebral thrombosis.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition and preparation method thereof, particularly a kind of pharmaceutical composition for the treatment of cerebral thrombosis and preparation method thereof and new pharmaceutical use.
Background technology
In prior art, for the disease of cerebrovascular aspect, at present common have cerebrovascular sclerosis, narrow, thromboembolism, wind among the traditional Chinese medical science is referred to as again.Because growth in the living standard, the raising of industrial and agricultural production level, people participate in blue-collar minimizing directly, cause a large amount of increase of disease of cardiovascular and cerebrovascular vessel, so paid attention to very much in research aspect this, about the report and medicine also a lot, many kinds such as, XINNAOKANG logical, Moschus antithrombotic pill, XUESHUANXINMAINING capsule such as BUCHANG NAOXINTONG JIAONANG, brain plug, this does not also comprise many hospital internal preparations, be the medicine of this aspect disease of treatment, in numerous similar medicines and the invention declared, identical with present technique finds as yet.
Summary of the invention
One object of the present invention is to disclose a kind of pharmaceutical composition; Another object of the present invention is to disclose a kind of pharmaceutical composition for the treatment of cerebral thrombosis; The 3rd purpose of the present invention is to disclose this preparation of drug combination method and purposes.
The present invention seeks to be achieved through the following technical solutions:
The raw material of pharmaceutical composition of the present invention consists of:
Rhizoma Et Radix Notopterygii 20-60 weight portion Rhizoma Gastrodiae 30-80 weight portion Agkistrodon 20-60 weight portion
Scolopendra 15-30 weight portion Flos Chrysanthemi 20-60 weight portion Scorpio 15-30 weight portion
Squama Manis preparata 15-30 weight portion Hirudo 15-30 weight portion Tabanus 15-30 weight portion
Pheretima 15-30 weight portion Rhizoma Acori Graminei 20-60 weight portion Radix Salviae Miltiorrhizae 20-60 weight portion
Styrax 10-40 weight portion Benzoinum 15-30 weight portion golden bell core 20-60 weight portion
Herba Taxilli 30-60 weight portion Cortex Eucommiae (parched) 20-60 weight portion Herba Apocyni veneti 20-60 weight portion
Flos Carthami 20-60 weight portion Semen Persicae 20-60 weight portion Radix Paeoniae Alba 20-60 weight portion
Radix Angelicae Sinensis 20-60 weight portion Eupolyphaga Seu Steleophaga 20-60 weight portion Radix Angelicae Pubescentis 20-60 weight portion
Zaocys 30-60 weight portion Fructus Liquidambaris 20-60 weight portion Cortex Acanthopancis 20-60 weight portion
Herba Lycopodii 30-80 weight portion Myrrha 15-30 weight portion Fructus Gardeniae 30-60 weight portion
Radix Rehmanniae 40-80 weight portion Radix Astragali 20-60 weight portion Rhizoma Dioscoreae Nipponicae 20-60 weight portion
Retinervus Luffae Fructus 20-60 weight portion Rhizoma Homalomenae 20-60 weight portion Semen Benincasae 50-100 weight portion
Radix Rumicis 20-60 weight portion Caulis Trachelospermi 20-60 weight portion.
The raw material composition of pharmaceutical composition of the present invention is preferably:
Rhizoma Et Radix Notopterygii 30 weight portion Rhizoma Gastrodiaes 60 weight portion Agkistrodons 40 weight portions
Scolopendra 20 weight portion Flos Chrysanthemis 40 weight portion Scorpios 20 weight portions
Squama Manis preparata 20 weight portion Hirudos 20 weight portion Tabanuss 20 weight portions
Pheretima 20 weight portion Rhizoma Acori Gramineis 30 weight portion Radix Salviae Miltiorrhizaes 30 weight portions
Styrax 20 weight portion Benzoinumes 20 weight portion golden bell cores 30 weight portions
Herba Taxilli 40 weight portion Cortex Eucommiae (parched) 30 weight portion Herba Apocyni venetis 30 weight portions
The Flos Carthami 30 weight portion Semen Persicaes 30 weight portion Radix Paeoniae Albas 30 weight portions
Radix Angelicae Sinensis 30 weight portion Eupolyphaga Seu Steleophagas 30 weight portion Radix Angelicae Pubescentiss 30 weight portions
Zaocys 40 weight portion Fructus Liquidambaris 30 weight portion Cortex Acanthopanciss 30 weight portions
Herba Lycopodii 60 weight portion Myrrhas 20 weight portion Fructus Gardeniaes 40 weight portions
The Radix Rehmanniae 60 weight portion Radix Astragali 30 weight portion Rhizoma Dioscoreae Nipponicae 30 weight portions
Retinervus Luffae Fructus 30 weight portion Rhizoma Homalomenaes 30 weight portion Semen Benincasaes 70 weight portions
Radix Rumicis 30 weight portion Caulis Trachelospermis 30 weight portions.
The raw material composition of pharmaceutical composition of the present invention is preferably:
Rhizoma Et Radix Notopterygii 20 weight portion Rhizoma Gastrodiaes 70 weight portion Agkistrodons 30 weight portions
Scolopendra 30 weight portion Flos Chrysanthemis 28 weight portion Scorpios 28 weight portions
Squama Manis preparata 30 weight portion Hirudos 25 weight portion Tabanuss 15 weight portions
Pheretima 25 weight portion Rhizoma Acori Gramineis 28 weight portion Radix Salviae Miltiorrhizaes 50 weight portions
Styrax 15 weight portion Benzoinumes 25 weight portion golden bell cores 20 weight portions
Herba Taxilli 50 weight portion Cortex Eucommiae (parched) 30 weight portion Herba Apocyni venetis 50 weight portions
The Flos Carthami 20 weight portion Semen Persicaes 60 weight portion Radix Paeoniae Albas 23 weight portions
Radix Angelicae Sinensis 50 weight portion Eupolyphaga Seu Steleophagas 25 weight portion Radix Angelicae Pubescentiss 55 weight portions
Zaocys 35 weight portion Fructus Liquidambaris 450 weight portion Cortex Acanthopanciss 27 weight portions
Herba Lycopodii 70 weight portion Myrrhas 15 weight portion Fructus Gardeniaes 50 weight portions
The Radix Rehmanniae 45 weight portion Radix Astragali 45 weight portion Rhizoma Dioscoreae Nipponicae 28 weight portions
Retinervus Luffae Fructus 45 weight portion Rhizoma Homalomenaes 30 weight portion Semen Benincasaes 90 weight portions
Radix Rumicis 30 weight portion Caulis Trachelospermis 50 weight portions
The raw material composition of pharmaceutical composition of the present invention is preferably:
Rhizoma Et Radix Notopterygii 50 weight portion Rhizoma Gastrodiaes 35 weight portion Agkistrodons 45 weight portions
Scolopendra 15 weight portion Flos Chrysanthemis 50 weight portion Scorpios 15 weight portions
Squama Manis preparata 30 weight portion Hirudos 20 weight portion Tabanuss 30 weight portions
Pheretima 15 weight portion Rhizoma Acori Gramineis 55 weight portion Radix Salviae Miltiorrhizaes 25 weight portions
Styrax 10 weight portion Benzoinumes 28 weight portion golden bell cores 55 weight portions
Herba Taxilli 35 weight portion Cortex Eucommiae (parched) 55 weight portion Herba Apocyni venetis 25 weight portions
The Flos Carthami 58 weight portion Semen Persicaes 25 weight portion Radix Paeoniae Albas 50 weight portions
Radix Angelicae Sinensis 25 weight portion Eupolyphaga Seu Steleophagas 55 weight portion Radix Angelicae Pubescentiss 25 weight portions
Zaocys 60 weight portion Fructus Liquidambaris 20 weight portion Cortex Acanthopanciss 58 weight portions
Herba Lycopodii 40 weight portion Myrrhas 30 weight portion Fructus Gardeniaes 35 weight portions
The Radix Rehmanniae 75 weight portion Radix Astragali 25 weight portion Rhizoma Dioscoreae Nipponicae 55 weight portions
Retinervus Luffae Fructus 30 weight portion Rhizoma Homalomenaes 50 weight portion Semen Benincasaes 50 weight portions
Radix Rumicis 40 weight portion Caulis Trachelospermis 25 weight portions.
Get the above-mentioned composition crude drug, according to common process, add conventional adjuvant, make the dosage form of clinical acceptance, include but not limited to concentrated pill, capsule, drop pill, granule, tablet, soft capsule, slow releasing agent, oral liquid or lyophilized injectable powder.
Preparation of drug combination method of the present invention can also be: above raw material decocts with water, and decocts 0.5-1.5 hour at every turn, decocts 2-4 time, and each the decoction adds 4-10 times of water gaging, filters, and relative density is the thick paste I of 1.00-1.30 when being concentrated into 50-70 ℃, and is standby; Thick paste adds conventional adjuvant, according to common process, makes concentrated pill, capsule, drop pill, granule, tablet, soft capsule, slow releasing agent, oral liquid or the lyophilized injectable powder of clinical acceptance.
Following experimental example is used to further specify the present invention but is not limited to the present invention.
The 100 routine clinical observations of experimental example medicine treatment of the present invention cerebral thrombosis disease
One, physical data
100 routine patients all are the outpatient, wherein male 61 examples, women 39 examples: the oldest 83 years old, minimum 27 years old, the course of disease the longest 2-3 32 examples are arranged, the shortest one month 68 examples that have to a year and a half are suffered from 46 examples that have of left side cerebral thrombosis, suffer from 54 examples that have of right side cerebral thrombosis.
Two, diagnostic criteria: tcm diagnosis standard: apoplexy: the diseases such as hemiplegia that cause by cerebral thrombosis etc.
Three, criterion of therapeutical effect: clinic control: the development and the recurrence of the disease controlling development or the state of an illness that slows down.
Produce effects: return near health status by treating the back state of an illness, can be considered produce effects.
Effectively: after treatment, the state of an illness takes a turn for the better to some extent and recovers.
Invalid: before the treatment and treatment back is without any variation.
Four, Therapeutic Method: medicine is formed: bolus of drug of the present invention, every ball 6g, every day early, evening each once, (medicine) being taken before meal 1-2 ball.
Five, therapeutic outcome (seeing the following form)
The inventor is in the clinical position of decades, use decoction for the treatment of the present invention suffer from various degree cerebral thrombosis patient have 300 approximately surplus the people, by clinical observation for many years, constantly sum up checking, total effective rate can reach more than 95%, fact proved good effect, instant effect, effect is remarkable, the cure rate height, relapse rate is low, and is reliable and stable.
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Rhizoma Et Radix Notopterygii 30g Rhizoma Gastrodiae 60g Agkistrodon 40g
Scolopendra 20g Flos Chrysanthemi 40g Scorpio 20g
Squama Manis preparata 20g Hirudo 20g Tabanus 20g
Pheretima 20g Rhizoma Acori Graminei 30g Radix Salviae Miltiorrhizae 30g
Styrax 20g Benzoinum 20g golden bell core 30g
Herba Taxilli 40g Cortex Eucommiae (parched) 30g Herba Apocyni veneti 30g
Flos Carthami 30g Semen Persicae 30g Radix Paeoniae Alba 30g
Radix Angelicae Sinensis 30g Eupolyphaga Seu Steleophaga 30g Radix Angelicae Pubescentis 30g
Zaocys 40g Fructus Liquidambaris 30g Cortex Acanthopanacis Radicis 30g
Herba Lycopodii 60g Myrrha 20g Fructus Gardeniae 40g
Radix Rehmanniae 60g Radix Astragali 30g Rhizoma Dioscoreae Nipponicae 30g
Retinervus Luffae Fructus 30g Rhizoma Homalomenae 30g Semen Benincasae 70g
Radix Rumicis 30g Caulis Trachelospermi 30g.
Get the above-mentioned composition crude drug, add conventional adjuvant,, make the pill of clinical acceptance according to common process.
Embodiment 2:
Rhizoma Et Radix Notopterygii 20g Rhizoma Gastrodiae 70g Agkistrodon 30g
Scolopendra 30g Flos Chrysanthemi 28g Scorpio 28g
Squama Manis preparata 30g Hirudo 25g Tabanus 15g
Pheretima 25g Rhizoma Acori Graminei 28g Radix Salviae Miltiorrhizae 50g
Styrax 15g Benzoinum 25g golden bell core 20g
Herba Taxilli 50g Cortex Eucommiae (parched) 30g Herba Apocyni veneti 50g
Flos Carthami 20g Semen Persicae 60g Radix Paeoniae Alba 23g
Radix Angelicae Sinensis 50g Eupolyphaga Seu Steleophaga 25g Radix Angelicae Pubescentis 55g
Zaocys 35g Fructus Liquidambaris 450g Cortex Acanthopancis 27g
Herba Lycopodii 70g Myrrha 15g Fructus Gardeniae 50g
Radix Rehmanniae 45g Radix Astragali 45g Rhizoma Dioscoreae Nipponicae 28g
Retinervus Luffae Fructus 45g Rhizoma Homalomenae 30g Semen Benincasae 90g
Radix Rumicis 30g Caulis Trachelospermi 50g.
Get the above-mentioned composition crude drug, add conventional adjuvant,, make the capsule of clinical acceptance according to common process.
Embodiment 3:
Rhizoma Et Radix Notopterygii 20g Rhizoma Gastrodiae 70g Agkistrodon 30g
Scolopendra 30g Flos Chrysanthemi 28g Scorpio 28g
Squama Manis preparata 30g Hirudo 25g Tabanus 15g
Pheretima 25g Rhizoma Acori Graminei 28g Radix Salviae Miltiorrhizae 50g
Styrax 15g Benzoinum 25g golden bell core 20g
Herba Taxilli 50g Cortex Eucommiae (parched) 30g Herba Apocyni veneti 50g
Flos Carthami 20g Semen Persicae 60g Radix Paeoniae Alba 23g
Radix Angelicae Sinensis 50g Eupolyphaga Seu Steleophaga 25g Radix Angelicae Pubescentis 55g
Zaocys 35g Fructus Liquidambaris 450g Cortex Acanthopancis 27g
Herba Lycopodii 70g Myrrha 15g Fructus Gardeniae 50g
Radix Rehmanniae 45g Radix Astragali 45g Rhizoma Dioscoreae Nipponicae 28g
Retinervus Luffae Fructus 45g Rhizoma Homalomenae 30g Semen Benincasae 90g
Radix Rumicis 30g Caulis Trachelospermi 50g.
Get the above-mentioned composition crude drug, add conventional adjuvant,, make the oral liquid of clinical acceptance according to common process.
Embodiment 4:
Rhizoma Et Radix Notopterygii 30g Rhizoma Gastrodiae 60g Agkistrodon 40g
Scolopendra 20g Flos Chrysanthemi 40g Scorpio 20g
Squama Manis preparata 20g Hirudo 20g Tabanus 20g
Pheretima 20g Rhizoma Acori Graminei 30g Radix Salviae Miltiorrhizae 30g
Styrax 20g Benzoinum 20g golden bell core 30g
Herba Taxilli 40g Cortex Eucommiae (parched) 30g Herba Apocyni veneti 30g
Flos Carthami 30g Semen Persicae 30g Radix Paeoniae Alba 30g
Radix Angelicae Sinensis 30g Eupolyphaga Seu Steleophaga 30g Radix Angelicae Pubescentis 30g
Zaocys 40g Fructus Liquidambaris 30g Cortex Acanthopancis 30g
Herba Lycopodii 60g Myrrha 20g Fructus Gardeniae 40g
Radix Rehmanniae 60g Radix Astragali 30g Rhizoma Dioscoreae Nipponicae 30g
Retinervus Luffae Fructus 30g Rhizoma Homalomenae 30g Semen Benincasae 70g
Radix Rumicis 30g Caulis Trachelospermi 30g.
Above raw material decocts with water, and decocts 1 hour at every turn, decocts 3 times, and each the decoction adds 8 times of water, filters, and relative density is 1.28 thick paste I when being concentrated into 60 ℃, and is standby; Add conventional adjuvant,, make the granule of clinical acceptance according to common process.
Claims (6)
1. pharmaceutical composition for the treatment of cerebral thrombosis is characterized in that the crude drug of this pharmaceutical composition consists of:
Rhizoma Et Radix Notopterygii 20-60 weight portion Rhizoma Gastrodiae 30-80 weight portion Agkistrodon 20-60 weight portion
Scolopendra 15-30 weight portion Flos Chrysanthemi 20-60 weight portion Scorpio 15-30 weight portion
Squama Manis preparata 15-30 weight portion Hirudo 15-30 weight portion Tabanus 15-30 weight portion
Pheretima 15-30 weight portion Rhizoma Acori Graminei 20-60 weight portion Radix Salviae Miltiorrhizae 20-60 weight portion
Styrax 10-40 weight portion Benzoinum 15-30 weight portion golden bell core 20-60 weight portion
Herba Taxilli 30-60 weight portion Cortex Eucommiae (parched) 20-60 weight portion Herba Apocyni veneti 20-60 weight portion
Flos Carthami 20-60 weight portion Semen Persicae 20-60 weight portion Radix Paeoniae Alba 20-60 weight portion
Radix Angelicae Sinensis 20-60 weight portion Eupolyphaga Seu Steleophaga 20-60 weight portion Radix Angelicae Pubescentis 20-60 weight portion
Zaocys 30-60 weight portion Fructus Liquidambaris 20-60 weight portion Cortex Acanthopancis 20-60 weight portion
Herba Lycopodii 30-80 weight portion Myrrha 15-30 weight portion Fructus Gardeniae 30-60 weight portion
Radix Rehmanniae 40-80 weight portion Radix Astragali 20-60 weight portion Rhizoma Dioscoreae Nipponicae 20-60 weight portion
Retinervus Luffae Fructus 20-60 weight portion Rhizoma Homalomenae 20-60 weight portion Semen Benincasae 50-100 weight portion
Radix Rumicis 20-60 weight portion Caulis Trachelospermi 20-60 weight portion.
2. a kind of pharmaceutical composition for the treatment of cerebral thrombosis as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Rhizoma Et Radix Notopterygii 30 weight portion Rhizoma Gastrodiaes 60 weight portion Agkistrodons 40 weight portions
Scolopendra 20 weight portion Flos Chrysanthemis 40 weight portion Scorpios 20 weight portions
Squama Manis preparata 20 weight portion Hirudos 20 weight portion Tabanuss 20 weight portions
Pheretima 20 weight portion Rhizoma Acori Gramineis 30 weight portion Radix Salviae Miltiorrhizaes 30 weight portions
Styrax 20 weight portion Benzoinumes 20 weight portion golden bell cores 30 weight portions
Herba Taxilli 40 weight portion Cortex Eucommiae (parched) 30 weight portion Herba Apocyni venetis 30 weight portions
The Flos Carthami 30 weight portion Semen Persicaes 30 weight portion Radix Paeoniae Albas 30 weight portions
Radix Angelicae Sinensis 30 weight portion Eupolyphaga Seu Steleophagas 30 weight portion Radix Angelicae Pubescentiss 30 weight portions
Zaocys 40 weight portion Fructus Liquidambaris 30 weight portion Cortex Acanthopanciss 30 weight portions
Herba Lycopodii 60 weight portion Myrrhas 20 weight portion Fructus Gardeniaes 40 weight portions
The Radix Rehmanniae 60 weight portion Radix Astragali 30 weight portion Rhizoma Dioscoreae Nipponicae 30 weight portions
Retinervus Luffae Fructus 30 weight portion Rhizoma Homalomenaes 30 weight portion Semen Benincasaes 70 weight portions
Radix Rumicis 30 weight portion Caulis Trachelospermis 30 weight portions.
3. a kind of pharmaceutical composition for the treatment of cerebral thrombosis as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Rhizoma Et Radix Notopterygii 20 weight portion Rhizoma Gastrodiaes 70 weight portion Agkistrodons 30 weight portions
Scolopendra 30 weight portion Flos Chrysanthemis 28 weight portion Scorpios 28 weight portions
Squama Manis preparata 30 weight portion Hirudos 25 weight portion Tabanuss 15 weight portions
Pheretima 25 weight portion Rhizoma Acori Gramineis 28 weight portion Radix Salviae Miltiorrhizaes 50 weight portions
Styrax 15 weight portion Benzoinumes 25 weight portion golden bell cores 20 weight portions
Herba Taxilli 50 weight portion Cortex Eucommiae (parched) 30 weight portion Herba Apocyni venetis 50 weight portions
The Flos Carthami 20 weight portion Semen Persicaes 60 weight portion Radix Paeoniae Albas 23 weight portions
Radix Angelicae Sinensis 50 weight portion Eupolyphaga Seu Steleophagas 25 weight portion Radix Angelicae Pubescentiss 55 weight portions
Zaocys 35 weight portion Fructus Liquidambaris 450 weight portion Cortex Acanthopanciss 27 weight portions
Herba Lycopodii 70 weight portion Myrrhas 15 weight portion Fructus Gardeniaes 50 weight portions
The Radix Rehmanniae 45 weight portion Radix Astragali 45 weight portion Rhizoma Dioscoreae Nipponicae 28 weight portions
Retinervus Luffae Fructus 45 weight portion Rhizoma Homalomenaes 30 weight portion Semen Benincasaes 90 weight portions
Radix Rumicis 30 weight portion Caulis Trachelospermis 50 weight portions.
4. a kind of pharmaceutical composition for the treatment of cerebral thrombosis as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Rhizoma Et Radix Notopterygii 50 weight portion Rhizoma Gastrodiaes 35 weight portion Agkistrodons 45 weight portions
Scolopendra 15 weight portion Flos Chrysanthemis 50 weight portion Scorpios 15 weight portions
Squama Manis preparata 30 weight portion Hirudos 20 weight portion Tabanuss 30 weight portions
Pheretima 15 weight portion Rhizoma Acori Gramineis 55 weight portion Radix Salviae Miltiorrhizaes 25 weight portions
Styrax 10 weight portion Benzoinumes 28 weight portion golden bell cores 55 weight portions
Herba Taxilli 35 weight portion Cortex Eucommiae (parched) 55 weight portion Herba Apocyni venetis 25 weight portions
The Flos Carthami 58 weight portion Semen Persicaes 25 weight portion Radix Paeoniae Albas 50 weight portions
Radix Angelicae Sinensis 25 weight portion Eupolyphaga Seu Steleophagas 55 weight portion Radix Angelicae Pubescentiss 25 weight portions
Zaocys 60 weight portion Fructus Liquidambaris 20 weight portion Cortex Acanthopanciss 58 weight portions
Herba Lycopodii 40 weight portion Myrrhas 30 weight portion Fructus Gardeniaes 35 weight portions
The Radix Rehmanniae 75 weight portion Radix Astragali 25 weight portion Rhizoma Dioscoreae Nipponicae 55 weight portions
Retinervus Luffae Fructus 30 weight portion Rhizoma Homalomenaes 50 weight portion Semen Benincasaes 50 weight portions
Radix Rumicis 40 weight portion Caulis Trachelospermis 25 weight portions.
5. as the preparation of drug combination method of the arbitrary described treatment cerebral thrombosis of claim 1-4, it is characterized in that this method is: get crude drug, according to common process, add conventional adjuvant, make concentrated pill, capsule, drop pill, granule, tablet, soft capsule, oral liquid.
6. as the application of the arbitrary described pharmaceutical composition of claim 1-4 in the medicine of preparation treatment cerebral thrombosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100640008A CN101244206B (en) | 2007-02-16 | 2007-02-16 | Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100640008A CN101244206B (en) | 2007-02-16 | 2007-02-16 | Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101244206A true CN101244206A (en) | 2008-08-20 |
| CN101244206B CN101244206B (en) | 2011-07-20 |
Family
ID=39945027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100640008A Expired - Fee Related CN101244206B (en) | 2007-02-16 | 2007-02-16 | Pharmaceutical combination for treating cerebral thrombus and preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101244206B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008658A (en) * | 2010-12-10 | 2011-04-13 | 冯学安 | Traditional Chinese medicine capsule for curing cerebral thrombosis |
| CN101549035B (en) * | 2009-04-21 | 2011-06-08 | 常熟雷允上制药有限公司 | Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof |
| CN101632732B (en) * | 2009-08-25 | 2011-10-26 | 刘卫丽 | Medicine for treating cerebrovascular diseases |
| EP2349300A4 (en) * | 2008-11-10 | 2013-03-13 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| CN104225275A (en) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition |
| CN108671191A (en) * | 2018-05-25 | 2018-10-19 | 侯平浩 | A kind of Chinese medicine composition for treating cranial vascular disease |
| CN109010701A (en) * | 2018-10-17 | 2018-12-18 | 北京太阳升高科医药研究股份有限公司 | A kind of preparation process and Chinese medicinal capsule of Chinese medicinal capsule |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151819C (en) * | 2001-08-21 | 2004-06-02 | 徐凤玉 | Cerebral thrombus treating traditional Chinese medicine |
-
2007
- 2007-02-16 CN CN2007100640008A patent/CN101244206B/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2349300A4 (en) * | 2008-11-10 | 2013-03-13 | Moleac Pte Ltd | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| US8852578B2 (en) | 2008-11-10 | 2014-10-07 | Moleac Pte. Ltd. | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| US9393290B2 (en) | 2008-11-10 | 2016-07-19 | Moleac Pte. Ltd. | Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| CN101549035B (en) * | 2009-04-21 | 2011-06-08 | 常熟雷允上制药有限公司 | Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof |
| CN101632732B (en) * | 2009-08-25 | 2011-10-26 | 刘卫丽 | Medicine for treating cerebrovascular diseases |
| CN102008658A (en) * | 2010-12-10 | 2011-04-13 | 冯学安 | Traditional Chinese medicine capsule for curing cerebral thrombosis |
| CN104225275A (en) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition |
| CN108671191A (en) * | 2018-05-25 | 2018-10-19 | 侯平浩 | A kind of Chinese medicine composition for treating cranial vascular disease |
| CN109010701A (en) * | 2018-10-17 | 2018-12-18 | 北京太阳升高科医药研究股份有限公司 | A kind of preparation process and Chinese medicinal capsule of Chinese medicinal capsule |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101244206B (en) | 2011-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101785844B (en) | Traditional Chinese medicine combination and preparation method thereof for dysentery treatment | |
| CN101244206B (en) | Pharmaceutical combination for treating cerebral thrombus and preparation thereof | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN101530566A (en) | Drug for treating rheumatism and rheumatoid disease | |
| CN100502904C (en) | Medication of Astragalus root for activating blood and the channels, and preparation method | |
| CN1305844A (en) | Medicine for treating congestive heart failure | |
| CN102755594A (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN101130030A (en) | Medicine composition for treating nephropathy and uses of the same | |
| CN101732616B (en) | Chinese medicinal composition for treating intracerebral hemorrhage and preparation method thereof | |
| CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
| CN101112606A (en) | Traditional Chinese medicine for treating enteritis | |
| CN101167976B (en) | Gastrosis-treating medicine | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN101168006B (en) | Medicine for treating gastric ulcer | |
| CN1268355A (en) | Yichanmanshenkang medicine for curing nephroses | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN1172672A (en) | Chinese medicinal herb composition for treating cancer | |
| CN103285329B (en) | Medicament for treating women dysmenorrhea and preparation method thereof | |
| CN101085088A (en) | Traditional Chinese medicine formula for treating prostatic hyperplasia | |
| CN102988650A (en) | Medicament for treating chronic nephritis and preparation method of medicament | |
| CN1327890C (en) | Chinese medicinal preparation for treating schizophrenia, its preparation and application method | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN101637536B (en) | Medicine for treating chronic sinusitis and preparation method thereof | |
| CN101167910B (en) | Oral liquid traditional Chinese medicine for treating cerebral thrombus sequelae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20170216 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |